News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KARL STORZ Endoscopy-America, Inc. Unveils Innovative Diagnostic Modality For Lung Cancer; Advanced Technology Uses Novel Combination Of Bronchoscopy And Special Light Spectrum



10/19/2005 5:11:44 PM

Karl Storz Endoscopy-America, Inc., a world leader in diagnostic and operative minimally invasive endoscopic technology, announces the D-Light Autofluorescence (AF) Bronchoscopy System for the early detection of lung cancer. Early detection provided by this combination of state-of-the-art endoscopy and the unique capabilities of autofluorescence technology may enable physicians to treat this malignancy at an early stage. Karl Storz remains the only U.S. company currently marketing an FDA-approved autofluorescence bronchoscopy system.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES